← Leaderboards
Brenda M Birmann
Brigham And Women'S Hospital
$7,864,273
Attributed
$9,934,409
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,934,409 · 6
By mechanism
R01$8,243,986 · 3
K07$796,064 · 1
R21$454,400 · 1
R37$439,959 · 1
Top collaborators
- Sophia S. Wang5 shared
- Svitlana Tyekucheva1 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Bing Lu$5,763,067
- Dariush Mozaffarian$28,150,783
- Karen H Costenbader$16,932,994
- Rulla M Tamimi$15,389,173
- Jonathan Abraham$3,836,355
Others in their field
Top investigators on “S Lymphoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$171,980,034
- Richard L Schilsky · University Of Chicago$120,036,663
- Joseph Sparano · Montefiore Medical Center (Bronx, Ny)$113,682,224
- Ronald T Mitsuyasu · University Of California Los Angeles$103,553,444
- Monica M Bertagnolli · Strang Cancer Prevention Center$61,393,123
- Charles A Coltman · Southwest Oncology Group$55,198,633
Research focus
S LymphomaCohortMalignant NeoplasmsHealth ProfessionalDiagnosisAdultEtiologyHealth StudyUnited StatesProspectiveNurses&AposRisk FactorsReportingCohort StudiesCessation Of LifeResearch PersonnelBody Mass IndexPersonsInflammationChronicBaseTissuesFollow-Up StudiesEpidemiology
Grant awards (21)
Geospatially modeled environmental risk factors for lymphoid malignancies$690,548
R01 · FY2025 · ES · contact PI
Geospatially modeled environmental risk factors for lymphoid malignancies$810,283
R01 · FY2024 · ES · contact PI
Comprehensive characterization of prostate stromal gene expression and association with lethal prostate cancer$439,959
R37 · FY2024 · CA · contact PI
Risk factors for molecular subtypes of NHL a prospective evaluation$664,031
R01 · FY2020 · CA
Risk factors for molecular subtypes of NHL a prospective evaluation$785,202
R01 · FY2019 · CA
Risk factors for molecular subtypes of NHL a prospective evaluation$668,277
R01 · FY2018 · CA
Risk factors for molecular subtypes of NHL a prospective evaluation$830,007
R01 · FY2017 · CA
Risk factors for molecular subtypes of NHL a prospective evaluation$752,796
R01 · FY2016 · CA
Diet patterns, aspirin use, obesity and multiple myeloma: a prospective analysis$202,245
R21 · FY2016 · CA · contact PI
A prospective analysis of peripheral blood cytokines and non-Hodgkin lymphoma$738,521
R01 · FY2015 · CA · contact PI
Diet patterns, aspirin use, obesity and multiple myeloma: a prospective analysis$252,155
R21 · FY2015 · CA · contact PI
A prospective analysis of peripheral blood cytokines and non-Hodgkin lymphoma$577,153
R01 · FY2014 · CA · contact PI
A prospective analysis of peripheral blood cytokines and non-Hodgkin lymphoma$560,228
R01 · FY2013 · CA · contact PI
A prospective analysis of peripheral blood cytokines and non-Hodgkin lymphoma$549,324
R01 · FY2012 · CA · contact PI
A prospective analysis of peripheral blood cytokines and non-Hodgkin lymphoma$617,616
R01 · FY2011 · CA · contact PI
Energy Balance, IGF Dysregulation and Multiple Myeloma$140,130
K07 · FY2010 · CA · contact PI
Energy Balance, IGF Dysregulation and Multiple Myeloma$140,130
K07 · FY2009 · CA · contact PI
Energy Balance, IGF Dysregulation and Multiple Myeloma$95,414
K07 · FY2009 · CA · contact PI
Energy Balance, IGF Dysregulation and Multiple Myeloma$140,130
K07 · FY2008 · CA · contact PI
Energy Balance, IGF Dysregulation and Multiple Myeloma$140,130
K07 · FY2007 · CA · contact PI
Energy Balance, IGF Dysregulation and Multiple Myeloma$140,130
K07 · FY2006 · CA · contact PI